M National regulatory authority participation agreement and undertaking for national regulatory focal point(s), Appendix 1, Part A PDF
M Note with respect to WHO PQT/MED Recommended Product Information additional to the SRA Approved Product Information for Products Prequalified via the Abridged (SRA) Route PDF
M Notes on the Design of Bioequivalence Study: Emtricitabine/Tenofovir disoproxil fumarate (20 February 2024) PDF